| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/13/2013 | CN102919943A Healthy drink-grape vine |
| 02/13/2013 | CN102919850A Composition for nutritional food and drugs |
| 02/13/2013 | CN102919829A Ganoderma lucidum product, as well as preparation method, application and using method thereof |
| 02/13/2013 | CN102919663A Preventing diseases in infants delivered via caesarean section |
| 02/13/2013 | CN102389385B Herba portulacae extract and solution, and preparation method and application |
| 02/13/2013 | CN102327292B Refined powder of sheep embryo and sheep placenta and preparation method thereof |
| 02/13/2013 | CN102327291B Stock solution of sheep embryo and sheep placental peptide and preparation method thereof |
| 02/13/2013 | CN102283979B Oral liquid containing cuora trifasciata and cordyceps |
| 02/13/2013 | CN102277288B Health wine and preparation method thereof |
| 02/13/2013 | CN102212446B Physical strength strengthening health-care medicinal liquor capable of tonifying kidney, strengthening yang and enhancing immunity and preparation method thereof |
| 02/13/2013 | CN101843362B Eucommia-clerodendrum bungei cigarette and production method thereof |
| 02/13/2013 | CN101829277B Oral preparation with immune enhancing function and preparation method thereof |
| 02/13/2013 | CN101829032B Dual-purpose toothpaste composition and preparation method thereof |
| 02/13/2013 | CN101810847B Inflammation-inhibiting compounds |
| 02/13/2013 | CN101759760B Preparation of fluorine-containing steroid hormone |
| 02/13/2013 | CN101357223B Preparation method of anti-stress agent for fishing |
| 02/13/2013 | CN101327201B Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372449 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372448 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma |
| 02/12/2013 | US8372406 Antitumoral and antiviral peptides |
| 02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | US8372397 Methods for regulation of stem cells |
| 02/12/2013 | US8372392 Lactobacillus paracasei strain LT12 as immunity regulatory agent |
| 02/12/2013 | CA2665707C Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 02/12/2013 | CA2588401C 17,20(z)-dehydro vitamin d analogs and their uses |
| 02/12/2013 | CA2557260C Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2462646C Adjuvanted meningococcus compositions |
| 02/12/2013 | CA2461740C Synthesis of cyclosporin analogs |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/12/2013 | CA2345817C Novel methods for therapeutic vaccination |
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/07/2013 | WO2013019966A1 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | WO2013019623A2 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013018733A1 1,5-naphthyridine derivative or salt thereof |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013018374A1 Ketone derivative and drug containing same |
| 02/07/2013 | WO2013018371A1 Biaryl ester derivative and drug containing same |
| 02/07/2013 | WO2013017480A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013017479A1 Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors |
| 02/07/2013 | WO2013017461A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/07/2013 | WO2013016805A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | WO2012123482A3 Isoxazolidine derivatives |
| 02/07/2013 | US20130035358 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035334 Inhibitors of bruton's tyrosine kinase |
| 02/07/2013 | US20130035333 Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders |
| 02/07/2013 | US20130035331 Thiazole and oxazole kinase inhibitors |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035320 Pyrrolidine derivatives |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035280 Method and means for identifying substances which inhibit IgE production |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130034595 Local administration of gallium compositions to treat pain |
| 02/07/2013 | US20130034586 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 02/07/2013 | US20130034584 Agent for use in the topical or local treatment of cervical dysplasias |
| 02/07/2013 | US20130034583 Compositions, methods and uses for expression of enterobacterium-associated peptides |
| 02/07/2013 | US20130034582 Reverse genetics methods for virus rescue |
| 02/07/2013 | US20130034580 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 02/07/2013 | US20130034577 Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia |
| 02/07/2013 | US20130034573 Vaccine compositions |
| 02/07/2013 | US20130034571 Methods for inducing in vivo tolerance |
| 02/07/2013 | US20130034569 Il-18 receptor antigen binding proteins |
| 02/07/2013 | US20130034557 Cancer-Related Glycopeptide Epitopes, Antibodies And Methods Of Use |
| 02/07/2013 | US20130034554 Antibodies to il-6 and use thereof |
| 02/07/2013 | US20130034518 Interleukin-12 P40 Variants with Improved Stability |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843636A1 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 02/07/2013 | CA2842872A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | CA2839805A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/06/2013 | EP2554552A1 Novel anti-cd98 antibody and use thereof |
| 02/06/2013 | EP2554544A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2552965A2 Anti-cd40 antibodies |
| 02/06/2013 | EP2552957A1 Antibodies with enhanced or suppressed effector function |
| 02/06/2013 | EP2552947A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 02/06/2013 | EP2552464A1 Use of bifidobacteria for preventing allergy in breastfed infants |
| 02/06/2013 | CN1993327B 3-Carbamoyl-2-pyridone derivative |
| 02/06/2013 | CN1378445B Drug releasing biodegradable fiber implant |
| 02/06/2013 | CN102918063A Anti-cd40 antibodies |
| 02/06/2013 | CN102918060A Antibodies against human CSF-1R and uses thereof |
| 02/06/2013 | CN102918042A 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds |
| 02/06/2013 | CN102918040A Purinone derivative |
| 02/06/2013 | CN102917726A Interferon analogs |
| 02/06/2013 | CN102917723A Soybean protein hydrolysate-containing antioxidant and use thereof |
| 02/06/2013 | CN102917715A Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents |
| 02/06/2013 | CN102917714A Growing up milks containing probiotic micro-organisms |
| 02/06/2013 | CN102917711A Heparan sulfate replacement therapy |
| 02/06/2013 | CN102917703A Novel EP4 agonist |